2 European Courts Reject Fosamax Patents
Teva Pharmaceutical Industries Ltd. said Monday that courts in the Netherlands and France have each found Merck Sharp & Dohme’s European patent related to alendronate to be invalid.
The Hague District Court revoked Merck’s European Patent Number 1,175,904 on Feb. 13 after determining it lacked inventive step,...
Already a subscriber? Click here to login